Preventive Effect of Wall. Ex Lindl. on Activated Carbon-induced Constipation in Mice
Overview
Authors
Affiliations
The aim of this study was to investigate the effects of Wall. ex Lindl. () on activated carbon-induced constipation in ICR mice. ICR mice were orally administered for 9 days. Body weight, defecation status, gastrointestinal (GI) transit and defecation times, in addition to the levels of motilin (MTL), gastrin (Gas), endothelin (ET), somatostatin (SS), acetylcholinesterase (AChE), substance P (SP) and vasoactive intestinal peptide (VIP) in serum were used to evaluate the preventive effects of on constipation. The laxative drug bisacodyl acted as a positive control. The time to the first defecation of a black stool for the normal, control, bisacodyl-treated (100 mg/kg), 200 and 400 mg/kg -treated mice was 84, 202, 126, 161 and 142 min, respectively. Following the consumption of 200 and 400 mg/kg or bisacodyl (100 mg/kg), the GI transit was reduced to 57.7, 74.6 and 90.2%, respectively, of the transit in normal mice. The serum levels of MTL, Gas, ET, AChE, SP and VIP were significantly increased and the serum levels of SS were reduced in the mice treated with compared with those in the untreated control mice (P<0.05). These results demonstrate that has preventive effects on constipation in mice, and a greater functional activity was observed when a higher concentration was administered.
Tan Q, Hu J, Zhou Y, Wan Y, Zhang C, Liu X Drug Des Devel Ther. 2021; 15:1971-1980.
PMID: 34007157 PMC: 8123977. DOI: 10.2147/DDDT.S309675.
Cao Y, Li K, Li Y, Tian X, Ba H, Wang A Pharm Biol. 2021; 58(1):176-183.
PMID: 33826488 PMC: 7048221. DOI: 10.1080/13880209.2020.1723648.
KSFY06 and geniposide counteract montmorillonite-induced constipation in Kunming mice.
Gan Y, Liang J, Diao W, Zhou X, Mu J, Pang L Food Sci Nutr. 2020; 8(9):5128-5137.
PMID: 32994973 PMC: 7500764. DOI: 10.1002/fsn3.1814.
Effects of Non-Starch Polysaccharides on Inflammatory Bowel Disease.
Nie Y, Lin Q, Luo F Int J Mol Sci. 2017; 18(7).
PMID: 28654020 PMC: 5535865. DOI: 10.3390/ijms18071372.
Tang H, Zhao T, Sheng Y, Zheng T, Fu L, Zhang Y Evid Based Complement Alternat Med. 2017; 2017:7436259.
PMID: 28386292 PMC: 5366227. DOI: 10.1155/2017/7436259.